-
Aug 13, 2026
The CBO estimate proves that price controls on pharmaceuticals increase rather than lower costs for patients. Lawmakers should protect biopharmaceutical leadership and reject price...
-
Aug 12, 2026
The CBO estimate proves that price controls on pharmaceuticals increase rather than lower costs for patients. Lawmakers should protect biopharmaceutical leadership and reject price...
-
Jul 31, 2026
Congress should deliver much-needed reforms to the 340B program, which would save taxpayers money and put an end to the abuse of 340B.
Aug 13, 2026The CBO estimate proves that price controls on pharmaceuticals increase rather than lower costs for patients. Lawmakers should protect biopharmaceutical leadership and reject price...
Jul 31, 2026Congress should deliver much-needed reforms to the 340B program, which would save taxpayers money and put an end to the abuse of 340B.